Fmoc-Glu(OtBu)-Opfp

Catalog No. :
ACPTLN850
CAS No. :
86061-04-3
Molecular Formula :
C30H26F5NO6
Molecular Weight :
591.53

IUPAC Name:5-(tert-butyl) 1-(perfluorophenyl) (((9H-fluoren-9-yl)methoxy)carbonyl)-L-glutamate

Fmoc-Glu(OtBu)-Opfp structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g98%$152.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameFmoc-Glu(OtBu)-Opfp
IUPAC Name5-(tert-butyl) 1-(perfluorophenyl) (((9H-fluoren-9-yl)methoxy)carbonyl)-L-glutamate
MDL No.MFCD00065647
Molecular FormulaC30H26F5NO6
Molecular Weight591.53
SMILESO=C(OC(C)(C)C)CC[C@@H](C(OC1=C(F)C(F)=C(F)C(F)=C1F)=O)NC(OCC2C3=C(C4=C2C=CC=C4)C=CC=C3)=O
InChI KeyAIDYQYOPUBOMTR-FQEVSTJZSA-N
SynonymFmoc-Glu(OtBu)-OPfp | HY-W017057 | 5-tert-Butyl 1-Pentafluorophenyl N-Fmoc-L-glutamate | N-alpha-(9-Fluorenylmethyloxycarbonyl)-L-glutamic-acid-gamma-t-butyl ester pentafluorphenyl ester (Fmoc-L-Glu(OtBu)-OPfp) | DTXSID80459315 | N-alpha-(9-Fluorenylmethy
CAS No.86061-04-3
PubChem CID11227121

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACPTLN850 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCBSX819 route compound structure diagram
    ACCBSX819204251-24-1 In Stock
  2. Plus
  3. ACVQAC527 route compound structure diagram
    ACVQAC527771-61-9 In Stock
  4. Then
  5. ACPTLN850 route product structure diagram
    ACPTLN85086061-04-3 In Stock
Inquiry

2. ACPTLN850 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACVQAC527 route compound structure diagram
    ACVQAC527771-61-9 In Stock
  4. Then
  5. ACPTLN850 route product structure diagram
    ACPTLN85086061-04-3 In Stock
Inquiry

Comments (0)